Correlation Between Vishay Precision and CERo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vishay Precision and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vishay Precision and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vishay Precision Group and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Vishay Precision and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vishay Precision with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vishay Precision and CERo Therapeutics.
Diversification Opportunities for Vishay Precision and CERo Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vishay and CERo is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Vishay Precision Group and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Vishay Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vishay Precision Group are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Vishay Precision i.e., Vishay Precision and CERo Therapeutics go up and down completely randomly.
Pair Corralation between Vishay Precision and CERo Therapeutics
Considering the 90-day investment horizon Vishay Precision Group is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vishay Precision Group is 15.01 times less risky than CERo Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 7.00 in CERo Therapeutics Holdings on October 9, 2024 and sell it today you would lose (5.61) from holding CERo Therapeutics Holdings or give up 80.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 34.55% |
| Values | Daily Returns |
Vishay Precision Group vs. CERo Therapeutics Holdings
Performance |
| Timeline |
| Vishay Precision |
| CERo Therapeutics |
Vishay Precision and CERo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vishay Precision and CERo Therapeutics
The main advantage of trading using opposite Vishay Precision and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vishay Precision position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.| Vishay Precision vs. Spectris plc | Vishay Precision vs. Mesa Laboratories | Vishay Precision vs. ESCO Technologies | Vishay Precision vs. Focus Universal |
| CERo Therapeutics vs. Safety Shot | CERo Therapeutics vs. Compania Cervecerias Unidas | CERo Therapeutics vs. Porvair plc | CERo Therapeutics vs. SNDL Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |